Abstracts

Skip to Main Content

Order by

T01 – Avelumab in Advanced Neuroendocrine Tumours (NET) of Gastroenteropancreatic or Lung Origin

Published in 2017 Listed under Poster, T

Chan

Abstract ID: 295

pdf Download Poster (579 KB)

T01 – Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery

Published in 2016 Listed under T

Eads

T02 – A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After At Least One Prior Regimen for Metastatic Disease

Published in 2017 Listed under T

Chauhan

Abstract ID: 250

T02 – A Phase II Trial of LEE011 in Combination with Everolimus in the Treatment of Advanced Well Differentiated Neuroendocrine Tumors of Foregut Origin

Published in 2016 Listed under T

Raj

T03 – Pilot Study: Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

Published in 2017 Listed under Poster, T

Hope

Abstract ID: 309

pdf Download Poster (671 KB)

T03 – SPINET: A Randomized, Double-blind, Placebo-controlled Phase III Study of Lanreotide Autogel/Depot (LAN) in Patients with Advanced Lung Neuroendocrine Tumors

Published in 2016 Listed under Poster, T

Reidy-Lagunes

pdf Download Poster (804 KB)

T04 – Multicenter Phase 2 Study of Nintedanib in Patients (pts) with Advanced Progressing Carcinoid Tumors

Published in 2017 Listed under T

Iyer

Abstract ID: 288

T05 – Phase 1/2 Open-Label Trial to Assess the Safety and Preliminary Efficacy of 177Lu-OPS201 as Peptide Receptor Radionuclide Therapy in Patients with Somatostatin Receptor-Positive, Progressive Neuroendocrine Tumors

Published in 2017 Listed under Poster, T

Nicolas

Abstract ID: 285

pdf Download Poster (849 KB)

T06 – Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET)

Published in 2017 Listed under Poster, T

Soulen

Abstract ID: 311

pdf Download Poster (475 KB)

T07 – ElevatION:NET-201 An Open-Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-Differentiated, Non-Functional NET of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-Differen

Published in 2017 Listed under Poster, T

Yao

Abstract ID: 242

pdf Download Poster (848 KB)

T1 - A Phase 1 Study of Fosbretabulin in Combination with Everolimus in Neuroendocrine Tumors (Grades 1-3) That Have Progressed After at Least One Prior Regimen for Metastatic Disease

Published in 2018 Listed under Poster, T

Abstract ID: 81

Aman Chauhan, Susanne Arnold, Stacey Slone, Emily Dressler, Lowell Anthony

pdf Download Poster (495 KB)

T2 - A Pilot Study of Pembrolizumab and Liver-Directed Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Liver Metastases

Published in 2018 Listed under Poster, T

Abstract ID: 110

Nicholas Fidelman Emily Bergsland Lawrence Fong

pdf Download Poster (246 KB)

T3 - Pembrolizumab-Based Therapy in Previously Treated High Grade Extrapulmonary Neuroendocrine Carcinomas

Published in 2018 Listed under Poster, T

Abstract ID: 96

Claire K. Mulvey, Claire Hooker, Jennifer A. Chan, Rahul Raj Aggarwal, Pelin Cinar, Thomas A. Hope, K. Pallav Kolli, Li Zhang, Susan Calabrese, Jennifer A. Grabowsky, Diane Reidy-Lagunes, Lawrence Fong, Nitya Prabhakar Raj, Emily K. Bergsland

pdf (2.24 MB) pdf Download Poster (2.24 MB)

T4 - A Pilot Phase 2 Study of Albumin-Bound Rapamycin Nanoparticles, ABI-009, in Patients with Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors (NETs) of the Lung or Gastroenteropancreatic System

Published in 2018 Listed under Poster, T

Abstract ID: 63

Robert A. Ramirez, Marc Matrana, Suma Satti, Ryan P. Griffin, Ramcharan Thiagarajan, J. Philip Boudreaux, Eugene A. Woltering

pdf Download Poster (385 KB)